Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Todos Medical Ltd (OP: TOMDF ) N/A UNCHANGED Last Price Updated: 12:46 PM EST, Mar 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0001 Today's Range N/A - N/A 52wk Range 0.0001 - 0.0007 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Todos Medical Announces Insolvency Proceedings in Israel December 22, 2023 NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel - (NewMediaWire) - December 22, 2023 - Todos Medical, Ltd. (OTCQB: TOMDF), an innovative healthcare solutions company, today announced that a trustee... Via NewMediaWire Topics Lawsuit Exposures COVID-19 Financial Legal Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic September 26, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Economy Exposures COVID-19 Economy Performance More News Read More Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid and Tollovir Ingredients August 30, 2023 Via NewMediaWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics March 28, 2023 Via NewMediaWire Exposures COVID-19 Todos Medical Begins Trading on the OTC Pink Marketplace March 27, 2023 Via NewMediaWire Todos Medical Supports Long COVID Awareness Day March 15, 2023 Via NewMediaWire Exposures COVID-19 Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders March 13, 2023 Via NewMediaWire Todos Medical Provides Corporate Update February 23, 2023 Via NewMediaWire Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics February 14, 2023 Via NewMediaWire CapitalGainsReport: Today’s OTC Bounce Watchlist (TOMDF, PHIL, RGBP, AIAD) February 08, 2023 Via News Direct Exposures COVID-19 Todos Medical to Present at the RHK 2022 Disruptive Growth Conference December 06, 2022 Via NewMediaWire Todos Medicals 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022 November 29, 2022 Via NewMediaWire Todos Medical to Attend World Antiviral Congress November 22, 2022 Via NewMediaWire Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network November 16, 2022 Via NewMediaWire Todos Medical Announces Third Quarter 2022 Financial Results November 15, 2022 Via NewMediaWire Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022 November 14, 2022 Via NewMediaWire Todos Medical Terminates Tollovid Products License & Distribution Agreement with T-Cell Protect Hellas S.A. November 10, 2022 Via NewMediaWire Todos Medical Announces BioFuture NYC 2022 Presentation November 04, 2022 Via NewMediaWire Most Active On The OTC Markets In September – A Look Back As October Comes To A Close October 27, 2022 Via Benzinga Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA October 14, 2022 Via NewMediaWire Exposures Product Safety Todos Medical Provides Corporate Update October 11, 2022 Via NewMediaWire Exposures COVID-19 Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics October 06, 2022 Via NewMediaWire Exposures COVID-19 Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform September 30, 2022 Via NewMediaWire Topics Intellectual Property Exposures Intellectual Property Todos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest September 27, 2022 Via NewMediaWire Todos Medical Enters Into $50M Contract to Supply Tollovid and CBD Products to Retail Distributor Company Nerd Hemp September 22, 2022 Via NewMediaWire Topics Artificial Intelligence Supply Chain Exposures Artificial Intelligence Supply Chain Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.